Quantcast

Latest Uterine serous carcinoma Stories

Genomics Help Improve Endometrial Cancer Treatment
2013-05-02 07:54:13

redOrbit Staff & Wire Reports - Your Universe Online Adding genomics-based testing to standard patient evaluation process could drastically alter the recommended treatment program for women with endometrial cancer, as well as the classification of that form of cancerous tumor, claims research published Thursday in the journal Nature. As part of the study, investigators from The Cancer Genome Atlas (TCGA) Research Network analyzed endometrial cancer tumor samples from 373 patients...

2010-11-01 21:06:33

African Americans are more likely to have a recurrence of uterine cancer despite undergoing a total hysterectomy or a hysterectomy followed by radiation therapy, according to researchers at Henry Ford Hospital in Detroit. "The African American patients in our study had similar surgeries and radiation therapy as the Caucasian patients in the study. So access to care certainly wasn't a factor in race being identified as a negative predictor for outcome," says lead author Mohamed Elshaikh, M.D.,...

2010-09-09 09:10:00

(Ivanhoe Newswire) -- Researchers have identified a genetic signature that allows doctors to determine which patients with early-stage non-small cell lung cancer are at high risk for developing disease reoccurrence and in due course may benefit from chemotherapy after surgery. "The findings give patients and their doctors a clearer map of the appropriate post-operative treatment route to follow.  Not all patients benefit from chemotherapy after surgery and those with less aggressive...

2010-07-12 13:27:00

IRVINE, Calif., July 12 /PRNewswire/ -- OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today that it has completed license agreements with key Norwegian cancer researchers. The agreements allow OvaGene to validate two new promising genomic technologies with the intention of developing these into clinical laboratory tests. Validation studies and the subsequent...

2010-02-25 13:59:15

The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and neck squamous cell carcinoma patients before treatment is a strong predictor of disease-specific survival, overall survival and disease-free survival, while pretreatment SUVmax for lymphodenopathy is strongly associated with distant metastasis, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and...

2009-12-12 12:03:58

Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin. Patients using Herceptin and chemotherapy at the same time had a relative 25 percent reduction in the risk of recurrence of cancer or death, compared with women who used Herceptin after chemotherapy, says Edith Perez,...

2009-11-02 09:00:19

High-risk melanoma patients who are treated with radiation after surgery have a significantly lower risk of their cancer returning to the lymph nodes (19 percent), compared to those patients who do not have radiation therapy (31 percent), according to the first randomized study of its kind presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). "Results of this trial now confirm the place of radiation therapy in...

2009-06-03 07:54:01

A new surgical technique is providing hope for women with early-stage cervical cancer. Traditionally, women with early-stage cervical cancer undergo a radical hysterectomy, a procedure with a high rate of tumor recurrence that often causes damage to surrounding tissues, leading to bladder and bowel dysfunction. Using a new technique called total mesometrial resection (TMMR), surgeons remove less tissue more accurately, causing less damage to the autonomic nervous system and reducing surgical...

2008-08-20 03:00:14

SCIENTISTS have found a way to detect an aggressive form of bowel cancer. The UK-led team say it should lead to accurate diagnosis and effective chemotherapy treatment. Bowel cancer is the third most common cancer in the UK, with 36,000 new cases every year. A study by Durham University and Stem-Cell Institute discovered people with a stem-cell protein called Lamin A were more likely to have an aggressive form of the disease. The team will now develop a test for NHS use. Professor...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.